ASSESSMENT OF VISCERAL ADIPOSITY BY NUTRITIONAL ULTRASOUND IN OVERWEIGHT AND OBESE PATIENTS TREATED WITH SEMAGLUTIDE 2.4 MG

Sep 6, 2026 — 01:15 pm - 1:22 PM
Hall Europa - Stage 3